Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000233734

Medchemexpress LLC 4-N-[4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]-1-N-(oxan-4-yl)cyclohexane-1,4-diamine | 1619903-54-6 | 99.9% | 100 MG
SDP

Supplier:  Medchemexpress LLC HY12293100MG

Encompass_Preferred

LY2857785 is a type I reversible, ATP-competitive kinase inhibitor that potently inhibits CDK9 and also targets transcriptional kinases CDK8 and CDK7. It is supplied as a high-purity research compound for in vitro studies of transcriptional regulation and CDK9-dependent signaling.

  • Potent CDK9 inhibitor with IC50 ≈ 11 nM.
  • Also inhibits CDK8 (IC50 ≈ 16 nM) and CDK7 (IC50 ≈ 246 nM).
  • High purity suitable for biochemical and cell-based assays.
  • Supplied as a solid powder with molecular weight 448.60 and formula C26H36N6O.
  • For research use only; not for human or veterinary use.

Catalog No. 50-002-33734


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.